U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Animal & Veterinary
  3. Development & Approval Process
  4. Drugs with Veterinary Feed Directive (VFD) Marketing Status
  1. Development & Approval Process

Drugs with Veterinary Feed Directive (VFD) Marketing Status

This list represents the medically important antimicrobials approved for use in or on animal feed that require a VFD, including those that transitioned from over-the-counter (OTC) to VFD marketing status upon completion of the implementation of Guidance for Industry (GFI) #213.

Please note that as a result of the implementation of GFI #213, approvals for penicillin alone or penicillin in fixed combination with chlortetracycline/sulfamethazine for use in animal feed have been voluntarily withdrawn. Additionally, the approval for oleandomycin was voluntarily withdrawn in 2017.

All feed uses of the following drugs, alone and in a combination with another drug(s), require a VFD:

Drugs that require a VFD

Established drug name
apramycin
avilamycin1
chlortetracycline (CTC)
chlortetracycline/sulfamethazine2
erythromycin
florfenicol1
hygromycin B
lincomycin
oxytetracycline/neomycin2
sulfadimethoxine/ormetoprim2
sulfamerazine
sulfaquinoxaline
tilmicosin1
tylosin
tylosin/sulfamethazine2
tylvalosin1
virginiamycin

1Drug product that has been VFD since its approval, and continues to require a VFD

2Fixed-ratio, combination drug

Note: Some of the VFD drugs on the list above may not be marketed at this time. If you have questions regarding the availability of a VFD drug, contact your local distributor.

Additional Resources

 

Back to Top